Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 25 May 2026 – 20 Aug 2026, limited by Axis Nifty Capital Markets Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Axis Nifty Capital Markets Index Fund | Nifty 500 |
|---|---|---|
| 25 May 2026 | ₹100.00 | ₹100.00 |
| 01 Jun 2026 | ₹95.04 | ₹97.86 |
| 09 Jun 2026 | ₹93.95 | ₹97.56 |
| 16 Jun 2026 | ₹97.80 | ₹100.30 |
| 23 Jun 2026 | ₹97.31 | ₹100.36 |
| 30 Jun 2026 | ₹96.34 | ₹100.29 |
| 08 Jul 2026 | ₹94.57 | ₹99.91 |
| 15 Jul 2026 | ₹97.81 | ₹101.46 |
| 22 Jul 2026 | ₹94.32 | ₹100.94 |
| 29 Jul 2026 | ₹93.57 | ₹101.85 |
| 06 Aug 2026 | ₹92.31 | ₹103.49 |
| 13 Aug 2026 | ₹94.65 | ₹103.18 |
| 20 Aug 2026 | ₹95.54 | ₹102.54 |
| Metric | Axis · Regular NAV ₹9.63 Very High risk Unrated | Category median Index Funds · 366 funds |
|---|---|---|
| — | +5.43% | |
| — | +8.41% | |
| — | +8.95% | |
| — | +11.28% | |
| -4.46% | +7.40% | |
| -12.05% | — | |
| — | +11.37% | |
| — | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 18.85% | 13.88% | |
| — | 0.25 | |
| — | 0.35 | |
| -8.83% | -16.66% | |
| Nifty 500 | — | |
| — | +0.30% | |
| — | 1.00 | |
| — | 101.3% | |
| — | 98.8% | |
| 1.91% | 0.96% | |
| ₹36.10Cr | ₹182.17Cr | |
| Up to 0.25% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| — | 35% | |
| Rohit Gautam | — | |
| 25 May 2026 | — | |
| 17 | — | |
| 82.4% | — | |
| -1.6% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.